Navigation Links
Divine Skin Rolls Out Polaris API Solution 9: A New Technology for Physicians
Date:11/9/2011

MIAMI BEACH, Fla., Nov. 9, 2011 /PRNewswire/ -- Biotech developer Divine Skin Inc. (OTC Bulletin Board: DSKX) which has been expanding the topical hair-growth segment, is rolling out that market's newest, most potent, only customizable system, Polaris API Solution 9, to be supplied by physicians for treatment through multiple methods of action.

With well-established materials like minoxidil sulfate, finasteride, alfatradiol, and other active ingredients, Polaris API Solution 9 is the most complete solution that can be used for hair loss, either by prescription or over the counter configured to the individual needs of the patient by physicians. The current sales leader contains only 5% minoxidil in a standard carrier.

"We are launching a new category," declared CEO Daniel Khesin, speaking on a conference call with investors. "We expect this line to change the game and to offer a powerful new tool for dermatologists that can really make a difference in their approach to treatment."

Half of all men will experience some hair loss by age 50, and they can only purchase the customized Polaris product through physicians, who can create the potent mix of active pharmaceutical ingredients (API).

Divine Skin, which posted revenue of $5.4 million in 2010 — up 55 percent over the previous year — creates a major new revenue stream with Polaris API Solution 9, and stockholders expect to benefit for several years.

In published clinical trials, each major component of the new API — minoxidil sulfate, finasteride, and alfatradiol — has proven to inhibit androgenic alopecia (male pattern baldness) effectively. The system also includes other auxiliary agents like apple polyphenol, copper peptides, nutrients, and conditioners to enhance the formula further.

"With very few options available," says Khesin, "Polaris API Solution 9
'/>"/>

SOURCE Divine Skin Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Divine Skin Posts Record Sales for 2010: Up 55% Over 2009
2. Divine Skin Announces Four Deals for Explosive Distribution Growth
3. First-quarter 2011 Sales Reach $2.25M — 126% Growth Over Q1 of 2010 — for Biotech Developer Divine Skin
4. Robin Powell Becomes President at Biotech Leader Divine Skin (DSKX)
5. Biotech Developer Divine Skin (DSKX) Debuts New Hair-Growth Molecule Nanoxidil
6. Divine Skin Posts Record Q2 Revenue of $2.33 Million, up 79 Percent From 2010
7. GeneNews rolls out ColonSentry(TM) test in additional Toronto area labs
8. Rice rolls out new nanocars
9. YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB
10. YM BioSciences enrolls first US patient in Phase II randomized, double-blind brain metastases trial for nimotuzumab
11. Polaris Enrolls First Patient in Phase 2 Clinical Trial of ADI-PEG 20 for the Treatment of Malignant Mesothelioma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... NY (PRWEB) January 14, 2014 EquitiesIQ, ... Alliqua, Inc. (OTCQB: ALQA). Alliqua is an emerging biomedical ... serve the wound care market. , Free report download: ... restructured with a seasoned management team and Board, which ...
(Date:1/14/2014)... and BETHESDA, Md. , ... joining together with two institutes from the National Institutes ... tools for bringing safer, more effective treatments to patients ... National Center for Advancing Translational Sciences (NCATS) and the ...
(Date:1/14/2014)... In recent years, growing suspicion about the ... development and promotion has led to unprecedented levels of ... concerns about the insidious impact of commercialization of research, ... to the world’s biggest pharmas for illegal marketing activities, ...
(Date:1/14/2014)... 2014 Global Record Systems, LLC, ... technology solutions for patients, physicians, the biopharmaceutical industry, ... today the signing of a three-year Research Collaboration ... Administration (FDA). This initiative is designed to ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Global Record Systems Announces Research Collaboration Agreement with FDA to Create a Novel “Big Data” Paradigm for Collection of Patient Safety and Outcomes Information 2
... ... Vestara announced today a strategic agreement with leading contract services ... Consortium (UHC) and nearly 14,000 members of Provista, LLC with the ... network includes acute hospitals and systems, academic medical centers, ambulatory care ...
... , AIX-EN-PROVENCE, France, Aug. 25 ... from the FDA for its Aixplorer(TM) ultrasound system and will ... States. Aixplorer is the only commercially available system of ... between conventional longitudinal waves and shear waves in tissue. ...
... NEW YORK, Aug. 25 Beth R. Jacobson (formerly Beth ... CELG ), under the claims of "misappropriation of an ... (THALOMID(R) and REVLIMID(R)) for the treatment of multiple myeloma. ... novel idea for treating multiple myeloma with thalidomide and is ...
Cached Biology Technology:Vestara Announces Strategic Agreement with Leading Contract Services Company Novation 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 4
(Date:4/24/2014)... West Virginia University researchers are the first to sequence ... view of eagle features that could lead to more ... question long-held assumptions about golden eagle vision, indicating that ... light as previously thought. The genome also suggests that ... than researchers realized. , Additionally, the genome provides ...
(Date:4/24/2014)... NY, April 24, 2014D-ribose is a commercially important ... and as a starting compound for synthesizing riboflavin ... Escherichia coli to increase the bacteria,s ability ... achieving more efficient industrial-scale production of this valuable ... Industrial Biotechnology , a peer-reviewed journal from Mary ...
(Date:4/24/2014)... a simple and cheap way of making a high-powered ... high-resolution microscope. , Costing less than a cent, the ... developing countries and remote areas. , The lens fabrication ... Australian National University (ANU) Research School of Engineering, who ... of Medical Research to find ways to transform the ...
Breaking Biology News(10 mins):Genome yields insights into golden eagle vision, smell 2Droplet lens 2
... at the Research School of Chemistry at The Australian National ... more than 20 years scientists have tried in vain to ... cells that are about to divide. , The research findings ... , In all cells, DNA is copied by a large ...
... to avoid smiling in public in order to hide their ... costly treatment options, such as veneers, crowns and bonding, served ... such stains and boost their self-esteem. , However, Kim ... how a new tooth whitening procedure he used on a ...
... have discovered the genetic controls which cause trees to ... well as the mechanism that causes them to begin ... understanding the basic genetics of tree growth. , The ... of Agricultural Sciences, Oregon State University and two other ...
Cached Biology News:ANU scientists crack DNA replication mystery 2Tetracycline plus teeth equal gray smile 2Tetracycline plus teeth equal gray smile 3Discovery may speed forest biotechnology 2Discovery may speed forest biotechnology 3